Asia Pacific Bioelectric Medicine Market 2020-2030 by Product Type (Implantable, Non-invasive), End User, and Country: Trend Forecast and Growth Opportunity

About the Report

About the Report

Bioelectric medicines, also known as electroceuticals, are medical devices that are used to restore health in patients. Bioelectric medicines function through neurostimulation and modulation of the nervous systems through electrical impulses. Asia Pacific bioelectric medicine market will grow by 9.3% annually with a total addressable market cap of USD 60.93 billion over 2021-2030 owing to the growing geriatric population and rising acceptance of bioelectric medicines.

Highlighted with 68 tables and 42 figures, this 140-page report Asia Pacific Bioelectric Medicine Market 2020-2030 by Product Type (Implantable, Non-invasive), End User, and Country: Trend Forecast and Growth Opportunity is based on a comprehensive research of the entire Asia Pacific bioelectric medicine market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2017-2019 and provides estimate/forecast from 2020 till 2030 with 2019 as the base year.

In-depth qualitative analyses include identification and investigation of the following aspects:

Market Structure

Growth Drivers

Restraints and Challenges

Emerging Product Trends & Market Opportunities

Porter's Fiver Forces

The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Asia Pacific bioelectric medicine market in every aspect of the classification from perspectives of Product Type, End User, and Country.

 

Based on Product Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

Implantable Bioelectric Medicine

o Cardiac Pacemaker

o Implantable Cardioverter Defibrillators (ICD)

o Spinal Cord Stimulators (split into Chronic Pain, Failed Back Syndrome (FBSS), Ischemia by application)

o Cochlear Implants

o Deep Brain Stimulators (split into Parkinson's Disease, Tremor, Depression, Other Deep Brain Stimulation Applications by application)

o Vagus Nerve Stimulators

o Sacral Nerve Stimulators (split into Urinary Incontinence and Fecal Incontinence by application)

o Retinal Implants

o Other Implantable Bioelectric Medicines

Non-invasive Bioelectric Medicine

o Transcutaneous Electrical Nerve Stimulators

o Transcranial Magnetic Stimulation (TMS)

o Pulsed Electromagnetic Field Therapy

o Other Non-invasive Bioelectric Medicines

 

Based on End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

Hospitals and Clinics

Research Institutes

Individual Users

 

Geographically, the following national/local markets are fully investigated:

Japan

China

South Korea

Australia

India

Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)

For each key country, detailed analysis and data for annual revenue are available for 2019-2030. The breakdown of the regional market by country and split of key national markets by Product Type and End User over the forecast years are also included.

 

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

 

Specifically, potential risks associated with investing in Asia Pacific bioelectric medicine market are assayed quantitatively and qualitatively through GMD's Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.

Key Players (this may not be a complete list and extra companies can be added upon request):

Abbott Laboratories

BIOTRONIK SE & Co. KG

Boston Scientific Corporation

Cochlear Limited

electroCore, Inc.

Inspire Medical Systems, Inc.

LivaNova PLC

Medtronic PLC

NeuroMetrix, Inc

Nevro Corp.

Nuvectra Corporation

OMRON CORPORATION

Pixium Vision

Second Sight Medical Products Inc

SetPoint Medical

Sonova Holding AG

St. Jude Medical, Inc.

Stimwave LLC

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Products


Companies

Key Players (this may not be a complete list and extra companies can be added upon request):

Abbott Laboratories

BIOTRONIK SE & Co. KG

Boston Scientific Corporation

Cochlear Limited

electroCore, Inc.

Inspire Medical Systems, Inc.

LivaNova PLC

Medtronic PLC

NeuroMetrix, Inc

Nevro Corp.

Nuvectra Corporation

OMRON CORPORATION

Pixium Vision

Second Sight Medical Products Inc

SetPoint Medical

Sonova Holding AG

St. Jude Medical, Inc.

Stimwave LLC

Table Of Content

Table Of Content

1 Introduction 6

1.1 Industry Definition and Research Scope 6

1.1.1 Industry Definition 6

1.1.2 Research Scope 7

1.2 Research Methodology 10

1.2.1 Overview of Market Research Methodology 10

1.2.2 Market Assumption 11

1.2.3 Secondary Data 11

1.2.4 Primary Data 11

1.2.5 Data Filtration and Model Design 12

1.2.6 Market Size/Share Estimation 13

1.2.7 Research Limitations 14

1.3 Executive Summary 15

2 Market Overview and Dynamics 17

2.1 Market Size and Forecast 17

2.1.1 Impact of COVID-19 on World Economy 18

2.1.2 Impact of COVID-19 on the Market 20

2.2 Major Growth Drivers 22

2.3 Market Restraints and Challenges 28

2.4 Emerging Opportunities and Market Trends 31

2.5 Porter's Fiver Forces Analysis 35

3 Segmentation of Asia Pacific Market by Product Type 39

3.1 Market Overview by Product Type 39

3.2 Implantable Bioelectric Medicine 41

3.2.1 Cardiac Pacemaker 43

3.2.2 Implantable Cardioverter Defibrillators (ICD) 44

3.2.3 Spinal Cord Stimulators 45

3.2.4 Cochlear Implants 46

3.2.5 Deep Brain Stimulators 47

3.2.6 Vagus Nerve Stimulators 48

3.2.7 Sacral Nerve Stimulators 49

3.2.8 Retinal Implants 50

3.2.9 Other Implantable Bioelectric Medicines 51

3.3 Non-invasive Bioelectric Medicine 52

3.3.1 Transcutaneous Electrical Nerve Stimulators 54

3.3.2 Transcranial Magnetic Stimulation (TMS) 55

3.3.3 Pulsed Electromagnetic Field Therapy 56

3.3.4 Other Non-invasive Bioelectric Medicines 57

4 Segmentation of Asia Pacific Market by End User 58

4.1 Market Overview by End User 58

4.2 Hospitals and Clinics 60

4.3 Research Institutes 61

4.4 Individual Users 62

5 Asia-Pacific Market 2020-2030 by Country 63

5.1 Overview of Asia-Pacific Market 63

5.2 Japan 66

5.3 China 69

5.4 Australia 72

5.5 India 74

5.6 South Korea 76

5.7 Rest of APAC Region 78

6 Competitive Landscape 80

6.1 Overview of Key Vendors 80

6.2 New Product Launch, Partnership, Investment, and M&A 86

6.3 Company Profiles 87

Abbott Laboratories 87

BIOTRONIK SE & Co. KG 90

Boston Scientific Corporation 94

Cochlear Limited 98

electroCore, Inc. 101

Inspire Medical Systems, Inc. 103

LivaNova PLC 105

Medtronic PLC 107

NeuroMetrix, Inc 111

Nevro Corp. 113

Nuvectra Corporation 115

OMRON CORPORATION 117

Pixium Vision 120

Second Sight Medical Products Inc 123

SetPoint Medical 126

Sonova Holding AG 128

St. Jude Medical, Inc. 130

Stimwave LLC 132

7 Investing in Asia Pacific Market: Risk Assessment and Management 134

7.1 Risk Evaluation of Asia Pacific Market 134

7.2 Critical Success Factors (CSFs) 137

Related Reports and Products 140


List Of Figure

Figure 1. Research Method Flow Chart 10

Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 13

Figure 3. Asia Pacific Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2020-2030 15

Figure 4. Asia Pacific Bioelectric Medicine Market, 2019-2030, USD mn 17

Figure 5. Impact of COVID-19 on Business 20

Figure 6. Primary Drivers and Impact Factors of Asia Pacific Bioelectric Medicine Market 22

Figure 7. Worldwide Geriatric Population (60 years and above) by Region, 2015 & 2030, million 26

Figure 8. World Population 65 and over, % of Total Population, 1950-2060 26

Figure 9. Primary Restraints and Impact Factors of Asia Pacific Bioelectric Medicine Market 28

Figure 10. Investment Opportunity Analysis 32

Figure 11. Porter's Fiver Forces Analysis of Asia Pacific Bioelectric Medicine Market 35

Figure 12. Breakdown of Asia Pacific Bioelectric Medicine Market by Product Type, 2020-2030, % of Sales Revenue 39

Figure 13. Asia Pacific Addressable Market Cap in 2021-2030 by Product Type, Value (USD mn) and Share (%) 40

Figure 14. Asia Pacific Bioelectric Medicine Market: Implantable Bioelectric Medicine, 2019-2030, USD mn 41

Figure 15. Asia Pacific Bioelectric Medicine Market: Cardiac Pacemaker, 2019-2030, USD mn 43

Figure 16. Asia Pacific Bioelectric Medicine Market: Implantable Cardioverter Defibrillators (ICD), 2019-2030, USD mn 44

Figure 17. Asia Pacific Bioelectric Medicine Market: Spinal Cord Stimulators, 2019-2030, USD mn 45

Figure 18. Asia Pacific Bioelectric Medicine Market: Cochlear Implants, 2019-2030, USD mn 46

Figure 19. Asia Pacific Bioelectric Medicine Market: Deep Brain Stimulators, 2019-2030, USD mn 47

Figure 20. Asia Pacific Bioelectric Medicine Market: Vagus Nerve Stimulators, 2019-2030, USD mn 48

Figure 21. Asia Pacific Bioelectric Medicine Market: Sacral Nerve Stimulators, 2019-2030, USD mn 49

Figure 22. Asia Pacific Bioelectric Medicine Market: Retinal Implants, 2019-2030, USD mn 50

Figure 23. Asia Pacific Bioelectric Medicine Market: Other Implantable Bioelectric Medicines, 2019-2030, USD mn 51

Figure 24. Asia Pacific Bioelectric Medicine Market: Non-invasive Bioelectric Medicine, 2019-2030, USD mn 52

Figure 25. Asia Pacific Bioelectric Medicine Market: Transcutaneous Electrical Nerve Stimulators, 2019-2030, USD mn 54

Figure 26. Asia Pacific Bioelectric Medicine Market: Transcranial Magnetic Stimulation (TMS), 2019-2030, USD mn 55

Figure 27. Asia Pacific Bioelectric Medicine Market: Pulsed Electromagnetic Field Therapy, 2019-2030, USD mn 56

Figure 28. Asia Pacific Bioelectric Medicine Market: Other Non-invasive Bioelectric Medicines, 2019-2030, USD mn 57

Figure 29. Breakdown of Asia Pacific Bioelectric Medicine Market by End User, 2020-2030, % of Sales Revenue 58

Figure 30. Asia Pacific Addressable Market Cap in 2021-2030 by End User, Value (USD mn) and Share (%) 59

Figure 31. Asia Pacific Bioelectric Medicine Market: Hospitals and Clinics, 2019-2030, USD mn 60

Figure 32. Asia Pacific Bioelectric Medicine Market: Research Institutes, 2019-2030, USD mn 61

Figure 33. Asia Pacific Bioelectric Medicine Market: Individual Users, 2019-2030, USD mn 62

Figure 34. Breakdown of APAC Bioelectric Medicine Market by Country, 2019 and 2030, % of Revenue 64

Figure 35. Contribution to APAC 2021-2030 Cumulative Revenue by Country, Value (USD mn) and Share (%) 65

Figure 36. Bioelectric Medicine Market in Japan, 2019-2030, USD mn 67

Figure 37. Bioelectric Medicine Market in China, 2019-2030, USD mn 69

Figure 38. Bioelectric Medicine Market in Australia, 2019-2030, USD mn 72

Figure 39. Bioelectric Medicine Market in India, 2019-2030, USD mn 74

Figure 40. Bioelectric Medicine Market in South Korea, 2019-2030, USD mn 76

Figure 41. Bioelectric Medicine Market in Rest of APAC, 2019-2030, USD mn 78

Figure 42. Growth Stage of Asia Pacific Bioelectric Medicine Industry over the Forecast Period 80

 

 

 


List Of Table

Table 1. Snapshot of Asia Pacific Bioelectric Medicine Market in Balanced Perspective, 2020-2030 16

Table 2. Growth Rate of World GDP, 2020-2022 19

Table 3. Projection of Asia Pacific Disease Incidences Treated by Bioelectric Medicine, 2019-2030, million 25

Table 4. World Health Spending by Region, USD bn, 2013-2020 27

Table 5. Selected Examples of Product Recalls 30

Table 6. Main Product Trends and Market Opportunities in Asia Pacific Bioelectric Medicine Market 31

Table 7. Asia Pacific Bioelectric Medicine Market by Product Type, 2019-2030, USD mn 39

Table 8. Asia Pacific Implantable Bioelectric Medicine Market by Product Type, 2019-2030, USD mn 42

Table 9. Asia Pacific Bioelectric Medicine Market: Spinal Cord Stimulators by Application, 2019-2030, USD mn 45

Table 10. Asia Pacific Bioelectric Medicine Market: Deep Brain Stimulators by Application, 2019-2030, USD mn 47

Table 11. Asia Pacific Bioelectric Medicine Market: Sacral Nerve Stimulators by Application, 2019-2030, USD mn 49

Table 12. Asia Pacific Non-invasive Bioelectric Medicine Market by Product Type, 2019-2030, USD mn 53

Table 13. Asia Pacific Bioelectric Medicine Market by End User, 2019-2030, USD mn 58

Table 14. APAC Bioelectric Medicine Market by Country, 2019-2030, USD mn 64

Table 15. Japan Bioelectric Medicine Market by Product Type, 2019-2030, USD mn 68

Table 16. Japan Bioelectric Medicine Market by End User, 2019-2030, USD mn 68

Table 17. China Bioelectric Medicine Market by Product Type, 2019-2030, USD mn 70

Table 18. China Bioelectric Medicine Market by End User, 2019-2030, USD mn 70

Table 19. Australia Bioelectric Medicine Market by Product Type, 2019-2030, USD mn 73

Table 20. Australia Bioelectric Medicine Market by End User, 2019-2030, USD mn 73

Table 21. India Bioelectric Medicine Market by Product Type, 2019-2030, USD mn 75

Table 22. India Bioelectric Medicine Market by End User, 2019-2030, USD mn 75

Table 23. South Korea Bioelectric Medicine Market by Product Type, 2019-2030, USD mn 77

Table 24. South Korea Bioelectric Medicine Market by End User, 2019-2030, USD mn 77

Table 25. Bioelectric Medicine Market in Rest of APAC by Country, 2019-2030, USD mn 79

Table 26. Spinal Cord Stimulation Device Market by Key Vendor, 2019, % 82

Table 27. Cochlear Implant Market by Key Vendor, 2019, % 82

Table 28. Pacemaker and ICD Market by Key Vendor, 2019, % 82

Table 29. FDA Approved Products of Key Vendors 83

Table 30. Abbott Laboratories: Company Snapshot 87

Table 31. Abbott Laboratories: Business Segmentation 88

Table 32. Abbott Laboratories: Product Portfolio 88

Table 33. Abbott Laboratories: Revenue, 2018-2020, USD mn 89

Table 34. BIOTRONIK SE & Co. KG: Company Snapshot 90

Table 35. Boston Scientific Corp.: Company Snapshot 94

Table 36. Boston Scientific Corp.: Business Segmentation 94

Table 37. Boston Scientific Corp.: Product Portfolio of Medical Devices 95

Table 38. Cochlear Limited: Company Snapshot 98

Table 39. Cochlear Limited: Operational Overview with Sales Revenue (USD mn) and Sales Volume (units), 2020-2021 98

Table 40. Cochlear Limited: Product Portfolio 99

Table 41. electroCore, Inc.: Company Snapshot 101

Table 42. Inspire Medical Systems, Inc..: Company Snapshot 103

Table 43. LivaNova PLC: Company Snapshot 105

Table 44. LivaNova PLC: Product Portfolio 106

Table 45. Medtronic Inc.: Company Snapshot 107

Table 46. Medtronic Inc.: Net Revenue by Segment, 2018-2020, USD bn 108

Table 47. Medtronic Inc.: Net Revenue by Region, 2017-2019, USD bn 108

Table 48. Medtronic Inc.: Product Portfolio of Medical Devices 108

Table 49. Medtronic Inc.: Product Portfolio of Bioelectric Medicine 109

Table 50. NeuroMetrix, Inc: Company Snapshot 111

Table 51. NeuroMetrix, Inc: Product Portfolio 112

Table 52. Nevro Corp.: Company Snapshot 113

Table 53. Nevro Corp.: Product Portfolio 114

Table 54. Nuvectra Corporation: Company Snapshot 115

Table 55. Omron Corporation: Company Snapshot 117

Table 56. Omron Corporation: Business Segmentation 118

Table 57. Pixium Vision: Company Snapshot 120

Table 58. Pixium Vision: Product Portfolio 121

Table 59. Second Sight Medical Products Inc: Company Snapshot 123

Table 60. Second Sight Medical Products Inc: Product Portfolio 124

Table 61. SetPoint Medical: Company Snapshot 126

Table 62. Sonova Holding AG: Company Snapshot 128

Table 63. Sonova Holding AG: Main Brands and Products 129

Table 64. St. Jude Medical, Inc.: Company Snapshot 130

Table 65. Stimwave LLC: Company Snapshot 132

Table 66. Stimwave LLC: Product Portfolio 133

Table 67. Risk Evaluation for Investing in Asia Pacific Market, 2020-2030 135

Table 68. Critical Success Factors and Key Takeaways 138

You can also purchase parts of this report. Do you want to check out a section wise price list?

Why Buy From US?

RRR
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story

reach
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Research
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

Insite
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Client Choose Us?

408564 Reports in repository
150+ Consulting project
100+ Analysts
8000+ Client Queries in 2022